-
Weekly Oral HIV Treatment Looks Good at Two Years
22 Oct 2025 12:51 GMT
… too high. Clinical trials of islatravir plus doravirine … #47;tenofovir alafenamide/emtricitabine) with viral suppression. The … lenacapavir plus islatravir experienced treatment-related adverse events, … -dose combination pill containing the two drugs is being …
-
MSD’s HIV duo non-inferior to SoC in Phase III trials
16 Oct 2025 13:25 GMT
… to SoC of bictegravir/emtricitabine/tenofovir alafenamide (BIC… III trials are currently assessing islatravir plus Gilead’s HIV drug, … weekly in a Phase II trial.
If approved, the … treatment option for patients with HIV, which could boost medication …
-
<![CDATA[Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials]]>
16 Oct 2025 05:39 GMT
… ;ISL with bictegravir/emtricitabine/tenofovir alafenamide (BIC … therapy (bART). Both trials previously demonstrated that DOR… vice president and chief medical officer, Merck Research Laboratories … , Oral, Two-Drug Regimen for Treatment of Adults with …
-
Merck announces new data from phase 3 trials of investigational, once─daily, oral, two─drug regimen of DOR/ISL in adults with virologically suppressed HIV─1 infection
16 Oct 2025 03:44 GMT
… suppressed on bictegravir/emtricitabine/tenofovir alafenamidei [ … trials.
Earlier this year, the US Food and Drug Administration (FDA … , active-controlled clinical trial evaluating the efficacy and … as the anchor medicine in the treatment regimens based …
-
Twice-Yearly Lenacapavir Could Be an Option for Initial HIV Treatment
16 Oct 2025 04:17 GMT
… for HIV treatment. In 2022, the Food and Drug Administration (FDA) approved Gilead … 3 received daily lenacapavir pills plus TAF/emtricitabine. Group 4 received … cells. Group 4 concluded the trial at that point. At 132 …
-
Merck's New HIV Treatment Works As Well As Top Drug In Late Trials
15 Oct 2025 16:54 GMT
… of innovative treatments in the pharmaceutical industry continues to … trial, the suppression was on bictegravir/emtricitabine… diabetic medication was <5% across treatment groups. … trials.
Earlier this year, the U.S. Food and Drug Administration (FDA …
-
5 Proven Strategies to Lower HIV Drug Costs
07 Oct 2025 17:34 GMT
… AIDS Program, dish out FDA-approved meds at no … HIV treatment. With patents expiring left and right, drugs like emtricitabine… empowering?
RELATED: HIV Treatment: Your Guide to Managing … doctor and begin to tap into an entire community of financial, medical …
-
Trump slashed funding for universities that helped create these 6 key drugs
06 Oct 2025 22:05 GMT
… medicines are a bottle of pills on a shelf - made by drug … molecule that looked promising.
Pharmaceutical company Parke-Davis ( … In 1989, they discovered emtricitabine, a key ingredient in … from replicating. The FDA designated the pill a “breakthrough.”
Liotta …
-
Gilead Sciences Settles Patent Litigations With Generic Drugmakers For Best-Selling HIV Drug: Analyst Cheers Longer Runway
06 Oct 2025 21:01 GMT
… U.S. Food and Drug Administration (FDA) to market generic versions … was Gilead’s best-selling drug in 2024. Biktarvy sales … contain Bictegravir (50 mg), Emtricitabine (200 mg), and Tenofovir … : Amgen To Sell Cholesterol Drug For Approximately 60% Discount
…
-
Pharmac proposes changes to make it easier to access HIV medicines
05 Oct 2025 02:56 GMT
… their treatment and reduce pharmacy visits.
Additionally, two HIV medicines - emtricitabine with … these medicines in their clinics for urgent use.
Pharmac’s Manager Pharmaceutical … to HIV medicines can be life changing. By making these treatments more …